Cargando…
NF‐κB signaling in inflammation and cancer
Since nuclear factor of κ‐light chain of enhancer‐activated B cells (NF‐κB) was discovered in 1986, extraordinary efforts have been made to understand the function and regulating mechanism of NF‐κB for 35 years, which lead to significant progress. Meanwhile, the molecular mechanisms regulating NF‐κB...
Autores principales: | Zhang, Tao, Ma, Chao, Zhang, Zhiqiang, Zhang, Huiyuan, Hu, Hongbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706767/ https://www.ncbi.nlm.nih.gov/pubmed/34977871 http://dx.doi.org/10.1002/mco2.104 |
Ejemplares similares
-
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study
por: Yu, Hui, et al.
Publicado: (2020) -
NF-κB signaling in inflammation
por: Liu, Ting, et al.
Publicado: (2017) -
The complexity of NF-κB signaling in inflammation and cancer
por: Hoesel, Bastian, et al.
Publicado: (2013) -
NF-κB in inflammation and renal diseases
por: Zhang, Haisong, et al.
Publicado: (2015) -
Pseudolaric acid B ameliorates synovial inflammation and vessel formation by stabilizing PPARγ to inhibit NF‐κB signalling pathway
por: Lu, Jiansen, et al.
Publicado: (2021)